FDA Authorizes Fourth Dose Of Moderna, Pfizer/BioNTech COVID-19 Vaccines For Older PeopleBenzinga • 03/29/22
Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and OlderBusiness Wire • 03/29/22
How Pfizer's $6.7 Billion Arena Pharmaceuticals Buyout Could Work for InvestorsThe Motley Fool • 03/26/22
BioNTech SE Sponsored ADR (BNTX) Gains But Lags Market: What You Should KnowZacks Investment Research • 03/17/22
BioNTech to Report Full Year and Fourth Quarter 2021 Financial Results and Operational Update on March 30, 2022GlobeNewsWire • 03/16/22
Pfizer and BioNTech Submit for U.S. Emergency Use Authorization of an Additional Booster Dose of their COVID-19 Vaccine for Older AdultsGlobeNewsWire • 03/15/22
BioNTech (BNTX), Regeneron Expand Agreement for Lung Cancer StudyZacks Investment Research • 03/09/22
BioNTech and Regeneron Expand Strategic Collaboration to Advance Clinical Development of FixVac and Libtayo® (cemiplimab) Combination in NSCLCGlobeNewsWire • 03/08/22